Trial: 202002050

Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of APL-101 in Subjects with Non-Small Cell Lung Cancer with c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Phase

I/II

Principal Investigator

Devarakonda, Siddhartha

Disease Site

Lung; Lung Cancer – Non-small Cell

Learn more about this study at: clinicaltrials.gov